Group 1 - The core point of the article is that the stock of Hand Return Group experienced a significant decline on its first day of trading in Hong Kong, opening over 7% lower than its issue price [1] - The opening price was reported at 7.5 HKD, while the issue price was set at 8.08 HKD [1]

Group 1 - The core viewpoint of the article is that Hand Return Group, a personal insurance intermediary service provider, has officially launched its IPO, planning to issue approximately 24.36 million shares at a price range of HKD 5.84 to HKD 8.08, with a listing date set for May 30 on the Hong Kong Stock Exchange [2] - The global offering consists of about 90% international placement (approximately 21.92 million shares) and 10% for public offering in Hong Kong (approximately 2.44 million shares), with cornerstone investors Tianjin Haitai Group and Luch Capital subscribing for a total of approximately HKD 49.55 million [2] - Based on the median issue price of HKD 7.28, the company's market capitalization post-listing is estimated to be around HKD 1.648 billion (approximately RMB 1.517 billion), with a price-to-sales (PS) ratio of 1.09 and a price-to-earnings (PE) ratio of 6.27 [2] Group 2 - According to the prospectus, Hand Return Group's revenue for 2022, 2023, and 2024 is projected to be RMB 806 million, RMB 1.634 billion, and RMB 1.387 billion, respectively, with adjusted net profits of RMB 75 million, RMB 253 million, and RMB 242 million, indicating a rising adjusted net profit margin reaching 17.4% by 2024 [3] - The company utilizes a digital platform to provide personal insurance transaction and service solutions, operating three major platforms: Xiao Yusan (online direct sales), Kachabao (agent distribution), and Niubao 100 (partner distribution), with over 1,900 insurance products distributed by the end of 2024 [3] - In 2023, the scale of personal insurance premiums in China reached RMB 500 billion, accounting for 14.6% of the total personal insurance market premiums, although the performance of insurance technology and intermediary platforms in the capital market has been mixed [3]

Core Viewpoint - Shenzhen Shouhui Technology Group Co., Ltd. has successfully passed the main board listing hearing on the Hong Kong Stock Exchange after multiple attempts, marking a significant step in its 18-month IPO journey [1][4]. Group 1: IPO Details - The company plans to globally offer 24.3584 million shares, with 22 million shares for international offering and 2.436 million shares for public offering in Hong Kong, at a price range of HKD 5.84 to HKD 8.08, aiming to raise up to HKD 196.8 million [1][3]. - The listing is expected to commence trading on May 30 [1]. Group 2: Financial Performance - The company has experienced significant financial volatility, with revenues of RMB 806 million, RMB 1.634 billion, and RMB 1.387 billion for the years 2022, 2023, and 2024 respectively, showing a 102.7% increase in 2023 followed by a 15.1% decline in 2024 [7]. - Cumulative net losses over two years reached RMB 4.92 billion, with losses of RMB 3.56 billion in 2023 and RMB 1.36 billion in 2024 [7][8]. Group 3: Business Model and Revenue Structure - The company primarily relies on insurance transaction commissions, with over 99% of its revenue coming from this source, while technology service income accounts for less than 1% [8]. - The "Niubao 100" platform contributed 62.8% of total insurance transaction service revenue in 2024, highlighting the vulnerability of its business model [6][8]. Group 4: Market Position and Competition - In 2023, the company held a 7.3% market share in the long-term personal insurance market, making it the second-largest online insurance intermediary in China [5]. - The company faces competition from major players like Ant Group and Tencent, which are pressuring smaller platforms [11]. Group 5: Governance and Internal Challenges - The company has faced internal governance issues, including a notable incident in 2020 involving a power struggle between co-founders, which raised concerns about its management stability [10]. - The company has also faced regulatory penalties for compliance violations, further intensifying investor concerns regarding its internal controls [10]. Group 6: Future Outlook - The company aims to use approximately 60% of the IPO proceeds to optimize its sales network and research and development, while the remaining funds will be allocated for liquidity and acquisitions [9]. - The future performance of the company remains uncertain, as it must navigate industry challenges and internal volatility post-IPO [11].

Group 1 - Shouhui Group has officially launched its IPO, offering approximately 24.36 million shares at a price range of HKD 6.48 to HKD 8.08 per share, with a listing date expected on May 30 [1] - The funds raised from the IPO will be used for optimizing the sales network, R&D investment, and acquisitions, which will enhance the company's market competitiveness and business scale [1] Group 2 - Heng Rui Pharmaceutical's shares surged by 32.24% in the dark market, closing at HKD 58.25 after an initial offering price of HKD 44.05, indicating strong market confidence in its future [2] - The company reported a revenue of 27.985 billion yuan for 2024, a year-on-year increase of 22.63%, and a net profit of 6.337 billion yuan, up 47.28% from the previous year [2] Group 3 - Wei Hong Group Holdings expects a net loss of approximately 48.5 million Macanese Patacas for the fiscal year 2024, compared to a net loss of about 27.8 million Macanese Patacas in 2023, attributed to a decline in revenue [3] - The group's revenue for the reporting year is expected to be around 9.7 million Macanese Patacas, down from approximately 105.8 million Macanese Patacas in the previous year [3] Group 4 - Longqi Technology plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its capital strength and international brand image, supporting its global business development [4] - The issuance will be subject to approval from the shareholders' meeting and relevant government and regulatory bodies [4] Group 5 - The Hang Seng Index closed at 23,544.31, down 1.19%, while the Hang Seng Tech Index fell by 1.70% to 5,251.75 [5] - The Yuqi Index also decreased by 1.19%, closing at 8,557.64 [5]

Core Viewpoint - The company, Shouhui Group, is launching an IPO with plans to issue 24.3584 million shares, aiming to raise up to HKD 196.8 million, and is set to list on May 30, 2025 [2][4]. Company Overview - Shouhui Group, established in 2015, is a life insurance intermediary service provider that offers digital insurance transaction and service solutions through platforms like Xiaoyusan, Kachabao, and Niubao100 [3]. - The company has distributed over 1,900 products, including more than 280 customized products and over 1,600 existing products from insurance companies [3]. Financial Performance - Revenue figures for Shouhui Group from 2022 to 2024 are as follows: HKD 806 million, HKD 1.634 billion, and HKD 1.387 billion, with corresponding gross margins of 34.8%, 33.8%, and 38.1% [4]. - Adjusted net profits for the same period are HKD 75 million, HKD 253 million, and HKD 242 million, with adjusted net profit margins of 9.3%, 15.5%, and 17.4% [4]. IPO Details - The IPO process began in 2014, with the company finally receiving approval for listing on May 15, 2025 [2]. - The IPO will include 21.9224 million shares for international offering and 2.436 million shares for public offering in Hong Kong [1][2]. - The expected market capitalization at the average issue price of HKD 7.28 is approximately HKD 1.648 billion (around RMB 1.517 billion) [2]. Industry Context - The insurance technology and intermediary sector is seeing increased interest in IPOs, with several companies, including Shouhui Group, actively seeking to go public [5]. - The market for life insurance in China was valued at RMB 3.8 trillion in 2023, with digital platforms accounting for approximately 14.6% of total premiums [6]. - Despite the enthusiasm for IPOs, the market has shown mixed reactions to newly listed insurance technology companies, with some experiencing significant declines post-IPO [6][7].

Core Viewpoint - Handback Group Limited is planning to launch an IPO from May 22 to May 27, 2025, with a global offering of approximately 24.36 million shares at a price range of HKD 6.48 to HKD 8.08 per share, aiming to raise between HKD 158 million and HKD 197 million [1][3]. Group 1: IPO Details - The expected total fundraising amount is approximately HKD 158 million to HKD 197 million, with a net amount of about HKD 116 million after deducting issuance costs, based on a median issue price of HKD 7.28 [3]. - If the overallotment option is fully exercised, the estimated net fundraising amount could reach approximately HKD 142 million [3]. - About 60% of the raised funds will be allocated to enhancing and optimizing the sales and marketing network and improving services over the next 60 months [3]. Group 2: Company Background - Handback Group, officially known as Shenzhen Handback Technology Group Co., Ltd., was established in January 2015 and has a registered capital of RMB 4.887 million [3]. - The major shareholders include Guangyao, Tianjin Handback Investment Co., Ltd., and others, with Guangyao holding 29.68% through Little Blue Light Ltd [4]. Group 3: Financial Performance - The company's revenue for 2022, 2023, and 2024 is estimated to be approximately RMB 806 million, RMB 1.634 billion, and RMB 1.387 billion, respectively, with net profits of RMB 131 million, -RMB 356 million, and -RMB 136 million [6][8]. - The adjusted net profit for the same years is approximately RMB 75 million, RMB 253 million, and RMB 242 million [8]. - The company experienced a significant revenue decline of approximately 47.9% in 2022 compared to 2021, primarily due to a decrease in income from insurance transaction services [9]. Group 4: Revenue Breakdown - Revenue from insurance transaction services decreased from approximately RMB 15.45 billion in 2021 to RMB 8.02 billion in 2022, a drop of 48.1% [9]. - For 2024, the revenue from insurance transaction services is projected to decline by 15.13%, primarily due to a reduction in long-term life insurance income [9]. - The income from the Niubao 100 platform is expected to decrease from RMB 11.01 billion in 2023 to RMB 8.65 billion in 2024 [9].

Investment Rating - The report assigns a basic factor and valuation rating of ★★★☆☆ to the company [4] Core Insights - The company is the second-largest online insurance intermediary in mainland China, holding a market share of 2.9% in the overall life insurance intermediary market as of 2023 [2] - Online intermediaries dominate the life insurance intermediary market in mainland China, accounting for 89.1% of total premiums in 2023 [2] - The company collaborates with over 110 insurance companies, including more than 70% of life insurance companies in mainland China, generating revenue primarily from commissions based on the premiums of policies distributed through its platform [2][3] Financial Data Summary - Revenue for the fiscal year ending December 31: - 2022: 8.06 billion RMB - 2023: 16.34 billion RMB - 2024: 13.87 billion RMB - Shareholder profit (loss) for the same period: - 2022: 1.31 billion RMB - 2023: -3.56 billion RMB - 2024: -1.36 billion RMB [4]

Core Viewpoint - After three submissions for an IPO, Shouhui Group Limited, a personal insurance intermediary service provider, has successfully passed the listing hearing at the Hong Kong Stock Exchange, marking a significant step towards entering the capital market [1] Company Overview - Established in 2015, Shouhui Group has built a substantial business footprint in the digital personal insurance transaction and service sector over ten years, leveraging three major platforms: Xiaoyusan, Kachabao, and Niubao100 to create a diversified distribution channel matrix [2] Financial Performance - Shouhui Group's revenue experienced fluctuations, rising from 806 million RMB in 2022 to 1.634 billion RMB in 2023, before declining to 1.387 billion RMB in 2024. The net profit shifted from a profit of 131 million RMB in 2022 to consecutive losses in the following two years [6][8] - The company's revenue structure shows a heavy reliance on long-term life insurance, which accounted for 59.4% of total revenue in 2023, but dropped to 33.8% in 2024 due to a significant decrease in commission rates [8][9] Market Position - In 2023, Shouhui Group held a 7.3% market share in China's online insurance intermediary sector, ranking second in terms of total premium for long-term personal insurance [4] - The company faces intense competition, with the leading player holding a 45.5% market share, highlighting the challenges in customer acquisition and resource integration [6] Challenges - The company has faced multiple challenges, including increased customer acquisition costs due to market saturation and regulatory changes impacting commission structures, leading to a decline in overall revenue [10][12] - Sales and marketing expenses rose from 98 million RMB in 2022 to 136 million RMB in 2024, reflecting the competitive pressures in the industry [10][11] Growth Potential - Despite challenges, Shouhui Group has a solid customer base, with over 1.6 million policyholders and 2.4 million insured individuals by 2024. The company aims to enhance its competitive edge through product customization and brand development [12][14] - The online insurance intermediary market in China is expected to continue expanding, with a projected compound annual growth rate of 32.3% from 2024 to 2028, indicating significant growth opportunities for Shouhui Group [14][15]

公司2022年度、2023年度、2024年度截至12月31日止，净利润分别为1.31亿元、-3.56亿元、-1.36亿元， 同比变动幅度为164.09%、-372.13%、61.78%。 手回集团(02621.HK)发布公告，公司拟全球发售2435.84万股股份，其中香港发售股份243.60万股，国际 发售股份2192.24万股，另有365.36万股超额配股权。招股日期为5月22日至5月27日，最高发售价8.08港 元，每手买卖单位400股，入场费约3264.59港元。 全球发售预计募资总额为1.77亿港元，募资净额1.16亿港元，募资用途为用于加强及优化公司的销售及 营销网络以及改善公司的服务；用于提升公司的研发能力及改善公司的技术基础设施；用于甄选合併、 收购及战略投资，包括继续寻求可补充或提升公司现有业务及对公司未来36至60个月的长远目标具有战 略裨益的潜在业务；用作营运资金及一般企业用途。 公司是中国领先的线上人身险中介服务提供商，致力于通过以保险客户为中心的数字化人身险交易及服 务平台，为保险客户提供定制保险服务解决方案。 公司引入海泰（香港）有限公司、韬越实业有限公司等基石投资者，将以发售价共认 ...